← All stocks

Viking Therapeutics, Inc.

VKTX Net selling

CIK 0001607678 #1525 in the set updated 18 Sep 2026

Bought (12 mo)

$149.91K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$22.25M

$0.00 on a plan · $2.70M straight out of an exercise

Sold at will

$19.56M

18 of 20 sales

Net

−$22.10M

−$19.41M against sales at will

By person

10 insiders · 21 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Lian Brian

President & CEO

—

$14.00M (6)

−$14.00M

2,572,441

2.21%

$86.09M

+8.7%

ZANTE GREG

Chief Financial Officer

—

$2.82M (6)

−$2.82M

212,204

0.1819%

$7.10M

+6.2%

Mancini Marianna

Chief Operating Officer

—

$2.73M (6)

−$2.73M

422,760

0.3624%

$14.15M

+13.2%

Rowland Charles A Jr

Director

—

$2.13M (1) scheduled

−$2.13M

33,150

0.0284%

$1.11M

+10.5%

FOEHR MATTHEW W

Director

—

$561.69K (1) scheduled

−$561.69K

135,186

0.1159%

$4.52M

+21.5%

Aubuchon Neil William

Chief Commercial Officer

$149.91K (1)

—

+$149.91K

4,475

0.0038%

$149.76K

—

MACARTNEY LAWSON

Director

—

51,115

0.0438%

$1.71M

+6.6%

SINGLETON J MATTHEW

Director

—

12,650

0.0108%

$423.33K

+33.2%

Kelly-Gemmell Dorothy Elizabeth

Director

—

6,333

0.0054%

$211.94K

—

Rouan Sarah Kathryn

Director

—

4,390

0.0038%

$146.91K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 19

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 2

Sales at will 18

Transactions with no price 0

Shares from compensation/vesting 923,980

History held since 15 Nov 2016